NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Hongkong Winhealth Pharma Group

Hongkong Winhealth Pharma Group

Private
Hong KongHealthcare & Life Scienceshttps://www.winhealth.hk/

Last Round

Series B

Oct 1, 2025

Total Funding Raised

$189.4M

Company Overview

Hongkong Winhealth Pharma Group is a biopharmaceutical company that focuses on the development, registration, and commercialization of innovative therapies for rare diseases and other critical medical conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Compliance, Patient Engagement

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

orphan drugspharmaceutical commercializationCDCOcontract development and commercialization organizationmarket accessrare disease therapeuticsdrug distributionGreater China market entryspecialty medicineregulatory affairspharma partnerpatient advocacyAI drug discoverypharma supply chain

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hongkong Winhealth Pharma Group Comparables

Compare Hongkong Winhealth Pharma Group with similar companies based on industry and business-model similarity.

Hongkong Winhealth Pharma Group comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sperogenix Therapeutics
80%
Golden Age Health
80%
CANbridge Pharma
78%

Hongkong Winhealth Pharma Group Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 1, 2025
Series AApr 1, 2019
Corporate FundingAug 15, 2018

Key People

Founding team and executive leadership

Tian Jing

Chief Financial Officer, Executive Director

Executive Team

Hongkong Winhealth Pharma Group Investors

Notable investors and investment history

Hongkong Winhealth Pharma Group investors
InvestorRounds
TD Capital Management LLCSeries B
Kaitai CapitalCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 6, 2025

    Monthly visitors grew 135% MoM, reaching 894.

Hongkong Winhealth Pharma Group Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hongkong Winhealth Pharma Group Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hongkong Winhealth Pharma Group's valuation, stock price, and market status.

Firmographic Details

HeadquartersHong Kong
Employee Range48
Year Founded2006
Last FundingOct 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.